摘要
Rivaroxaban (with initial increased dosage) may be used as a stand-alone therapy in patients with venous thromboembolism. %26lt;br%26gt;The development of new anticoagulant drugs opened several options in the management of venous thrombo-embolism. %26lt;br%26gt;The efficacy and safety of these new oral anticoagulants in specific population as elderly and those with renal impairment deserve future research. %26lt;br%26gt;At that time, only rivaroxaban is licensed in France, in the treatment of deep venous thrombosis.
- 出版日期2013-9